Currently out of the existing stock ratings of Gregory Renza, 231 are a BUY (79.93%), 58 are a HOLD (20.07%).

Gregory Renza

Work Performance Price Targets & Ratings Chart

Analyst Gregory Renza, currently employed at TRUIST, carries an average stock price target met ratio of 43.1% that have a potential upside of 36.31% achieved within 119 days.

Gregory Renza’s has documented 587 price targets and ratings displayed on 39 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on AGIO, Agios Pharm at 26-Dec-2025.

Wall Street Analyst Gregory Renza

Analyst best performing recommendations are on SPRB (SPRUCE BIOSCIENCES ).
The best stock recommendation documented was for SPRB (SPRUCE BIOSCIENCES ) at 3/13/2024. The price target of $150 was fulfilled within 1 day with a profit of $239.25 (61.46%) receiving and performance score of 614.64.

Average potential price target upside

of $137.12 (72.19%) on APTO (APTOSE BIOSCIENCES).
of $59.39 (52.53%) on JAZZ (JAZZ PHARMACEUTICALS PLC).
of $40.37 (75.04%) on ITRM (ITERUM THERAPEUTICS PLC).

ACAD ACADIA Pharmaceuticals APRE Aprea Therapeutics APTO Aptose Biosciences AVTX Avalo Therapeutics BLU BELLUS Health GMDA Gamida Cell Ltd INO Inovio Pharmaceuticals ITRM Iterum Therapeutics PLC MORF Morphic XNCR Xencor GBT Global Blood Therapeutics SGEN Seagen ADCT ADC Therapeutics SA RXDX Prometheus Biosciences VRCA Verrica Pharmaceuticals JAZZ Jazz Pharmaceuticals PLC AMGN Amgen IDYA Ideaya Biosciences LIFE aTyr Pharma NRIX Nurix Therapeutics NUVB Nuvation Bio PRVB Provention Bio SPRB Spruce Biosciences VIRX Viracta Therapeutics VSTM Verastem ARQL ArQule ALPN Alpine Immune Sciences CRMD CorMedix EXEL Exelixis PCRX Pacira Pharmaceuticals VRDN Viridian Therapeutics AGIO Agios Pharm BCYC Bicycle Therapeutics Ltd FULC Fulcrum Therapeutics FUSN Fusion Pharmaceuticals JSPR Jasper Therapeutics CATX Perspective Therapeutics CGON CG Oncology, Common stock CDTX Cidara Therapeutics

Show more stocks

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score